Cargando…
Misspecification of at‐risk periods and distributional assumptions in estimating COPD exacerbation rates: The resultant bias in treatment effect estimation
In trials comparing the rate of chronic obstructive pulmonary disease exacerbation between treatment arms, the rate is typically calculated on the basis of the whole of each patient's follow‐up period. However, the true time a patient is at risk should exclude periods in which an exacerbation e...
Autores principales: | Law, M., Sweeting, M.J., Donaldson, G.C., Wedzicha, J.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434805/ https://www.ncbi.nlm.nih.gov/pubmed/27966248 http://dx.doi.org/10.1002/pst.1798 |
Ejemplares similares
-
Misspecification of confounder-exposure and confounder-outcome associations leads to bias in effect estimates
por: Schuster, Noah A., et al.
Publicado: (2023) -
Model misspecification and bias for inverse probability weighting estimators of average causal effects
por: Waernbaum, Ingeborg, et al.
Publicado: (2022) -
MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation
por: Mercer, PF, et al.
Publicado: (2005) -
Acute Exacerbations of COPD
por: Wedzicha, J.A.
Publicado: (2002) -
Selection bias, investment decisions and treatment effect distributions
por: Wiklund, Stig Johan, et al.
Publicado: (2021)